Skp Labs Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 14-12-2024
- Paid Up Capital ₹ 3.10 M
as on 14-12-2024
- Company Age 28 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -43.80%
(FY 2022)
- Profit 72.01%
(FY 2022)
- Ebitda 91.32%
(FY 2022)
- Net Worth 2.77%
(FY 2022)
- Total Assets 0.64%
(FY 2022)
About Skp Labs
The Corporate was formerly known as Sri Kartikeya Chemicals Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 3.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mahesh Baldwa and Kartikeya Baldwa serve as directors at the Company.
- CIN/LLPIN
U24100TG1996PTC023744
- Company No.
023744
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Apr 1996
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Skp Labs?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahesh Baldwa  | Director | 09-Apr-1996 | Current |
| Kartikeya Baldwa | Director | 11-Nov-2003 | Current |
Financial Performance and Corporate Structure Insights of Skp Labs.
Skp Labs Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 43.8% decrease. The company also saw a substantial improvement in profitability, with a 72.01% increase in profit. The company's net worth moved up by a moderate rise of 2.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Skp Labs?
In 2021, Skp Labs had a promoter holding of 99.19% and a public holding of 0.81%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ixoreal Biomed Private LimitedActive 19 years 7 monthsMahesh Baldwa and Kartikeya Baldwa are mutual person
Ixoreal Biosciences Private LimitedActive 3 years 5 monthsMahesh Baldwa and Kartikeya Baldwa are mutual person
- Skyzoom Marketing Pvt.Ltd.Active 29 years 7 months
Mahesh Baldwa and Kartikeya Baldwa are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Skp Labs?
Unlock and access historical data on people associated with Skp Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Skp Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skp Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
